2021 annual financial data

Anika Therapeutics 2021 Operating cash flow margin

Direct answer

Operating cash flow margin was 5.68%.

Operating income was 2.62M USD and net income was 4.13M USD.
Operating cash flow was 8.4M USD.

Get free Anika Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
147.79M USD
Operating income
2.62M USD
Net income
4.13M USD
Operating cash flow
8.4M USD